ing manifestations related to RA from those of SCD in patients with joint complaints, independently of the genotype or severity of complications of SCD. It is strongly advised to keep… Click to show full abstract
ing manifestations related to RA from those of SCD in patients with joint complaints, independently of the genotype or severity of complications of SCD. It is strongly advised to keep in mind the possibility of RA coexistence when the clinical course of the painful crisis in SCD patients does not follow the expected trajectory. The prompt use of agents which target the underlying pathophysiology of RA remains the best option for the prevention of potential damage in these patients, who usually present with comorbidities due to SCD.
               
Click one of the above tabs to view related content.